SOLDOVIERI, Maria Virginia
 Distribuzione geografica
Continente #
NA - Nord America 3.789
EU - Europa 3.409
AS - Asia 1.112
SA - Sud America 301
AF - Africa 124
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 8.759
Nazione #
US - Stati Uniti d'America 3.712
RU - Federazione Russa 1.478
IE - Irlanda 630
SG - Singapore 466
CN - Cina 312
BR - Brasile 253
IT - Italia 183
UA - Ucraina 169
FI - Finlandia 160
AT - Austria 152
DE - Germania 147
SE - Svezia 133
GB - Regno Unito 128
CI - Costa d'Avorio 98
BE - Belgio 86
VN - Vietnam 78
IN - India 55
HK - Hong Kong 51
CA - Canada 49
FR - Francia 39
JP - Giappone 36
PL - Polonia 29
AR - Argentina 18
MX - Messico 18
ES - Italia 17
NL - Olanda 17
BD - Bangladesh 15
ZA - Sudafrica 15
ID - Indonesia 14
LT - Lituania 13
IR - Iran 12
TR - Turchia 11
AU - Australia 9
IQ - Iraq 9
CL - Cile 8
EU - Europa 8
IL - Israele 8
EC - Ecuador 7
CO - Colombia 6
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
PY - Paraguay 5
RO - Romania 5
KR - Corea 4
MD - Moldavia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
DK - Danimarca 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
PH - Filippine 2
VE - Venezuela 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GM - Gambi 1
GT - Guatemala 1
KE - Kenya 1
KW - Kuwait 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 8.759
Città #
Dallas 881
Dublin 627
Chandler 459
Moscow 455
Jacksonville 386
Singapore 224
Beijing 169
Ann Arbor 163
Vienna 147
New York 129
Wilmington 127
Ashburn 124
Helsinki 117
Abidjan 98
Woodbridge 91
Brussels 86
San Mateo 73
Boardman 67
Los Angeles 63
Princeton 57
Rome 52
Hong Kong 51
The Dalles 44
Houston 40
São Paulo 32
Molise 27
Tokyo 27
Ho Chi Minh City 26
Columbus 25
Dearborn 24
London 21
Warsaw 20
Chennai 17
Stockholm 17
Toronto 17
Poplar 16
Falls Church 15
Montreal 15
Redwood City 15
San Francisco 15
Brooklyn 13
Frankfurt am Main 13
Munich 13
Napoli 13
Phoenix 13
Hanoi 12
Hefei 12
Jakarta 12
Nanjing 12
Johannesburg 11
Boston 10
Kunming 10
Da Nang 9
Falkenstein 9
Mountain View 9
Naples 9
Norwalk 9
Orem 9
Atlanta 8
Auburn Hills 8
Augusta 8
Chicago 8
Mumbai 8
Santa Clara 8
Amsterdam 7
Denver 7
Brasília 6
Clearwater 6
Council Bluffs 6
Fortaleza 6
Milan 6
Seattle 6
Amman 5
Ankara 5
Baghdad 5
Charlotte 5
Curitiba 5
Mexico City 5
Nuremberg 5
Ottawa 5
Pune 5
Querétaro 5
Quito 5
Shenyang 5
Turku 5
Wroclaw 5
Wuhan 5
Zhengzhou 5
Belo Horizonte 4
Buenos Aires 4
Calgary 4
Campo Grande 4
City of London 4
Leawood 4
Manchester 4
Paris 4
Porto Alegre 4
Roseto Degli Abruzzi 4
Sacramento 4
Saint-maur-des-fossés 4
Totale 5.483
Nome #
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 253
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 233
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S-4 region of KCNQ2 causing benign familial neonatal convulsions 204
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 189
Autism and developmental disability caused by KCNQ3 gain-of-function variants 186
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 183
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 175
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 175
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 174
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 173
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 171
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 171
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 167
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 167
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation 166
The occurrence of a Kv7.4 potassium channel in neuronal mitochondria 164
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 164
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 162
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 161
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 159
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. 158
Cardiotoxic effects of antihistamines: From basics to clinics (... and back) 153
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 152
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 150
Addressing the use of PDIF-CN(2) molecules in the development of n-type organic field-effect transistors for biosensing applications 149
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 148
A new Italian FHM2 family: Clinical aspects and functional analysis of the disease-associated mutation 142
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs 140
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine 139
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 136
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 133
Expression, Localization, and Pharmacological Role of K(v)7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 131
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 130
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 130
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons. 129
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators 128
CORRELATING THE CLINICAL AND GENETIC FEATURES OF BENIGN FAMILIAL NEONATAL SEIZURES (BFNS) WITH THE FUNCTIONAL CONSEQUENCES OF THE UNDERLYING MUTATIONS 125
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+Channel Gating 123
Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A 120
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 120
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 117
Driving with no brakes: molecular pathophysiology of kv7 potassium channels 116
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits 115
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 114
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 114
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 109
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 108
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 106
Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists. 105
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 105
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 104
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 102
The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants 101
Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene 99
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 97
The ever changing moods of calmodulin: how structural plasticity entails transductional adaptability. 96
Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia. 94
Fluoxetine Treatment in Epilepsy of Infancy with Migrating Focal Seizures Due to KCNT1 Variants: An Open Label Study. 92
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants 92
Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC) 86
Gating consequences of charge neutralization of arginine residues in the S-4 segment of K(v)7.2, an epilepsy-linked K+ channel subunit 81
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 79
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel 76
Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 69
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties 67
The long and winding road to personalized medicine in KCNMA1-linked channelopathies revealed by novel variants associated with the Liang-Wang syndrome 64
null 58
Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes. 57
Totale 8.956
Categoria #
all - tutte 39.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021279 0 0 0 0 0 42 69 3 62 10 79 14
2021/2022402 13 65 4 13 42 44 12 35 75 43 26 30
2022/20231.807 225 80 30 181 133 169 11 79 780 59 42 18
2023/2024357 72 40 16 7 8 95 10 17 12 11 10 59
2024/20251.239 111 49 147 51 252 56 72 66 106 28 122 179
2025/20263.357 178 522 590 376 1.427 264 0 0 0 0 0 0
Totale 8.956